Common diabetes drug tested as potential brain shield for devastating genetic disease
NCT ID NCT04826692
Summary
This study tested whether metformin, a common diabetes medication, could help slow down the worsening of thinking and memory in people with Huntington's disease. For one year, 60 adult patients took either metformin or a placebo pill. Researchers measured changes in cognitive tests, movement, behavior, and daily function to see if the drug made a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Complejo Hospitalario de Albacete
Albacete, Castille-La Mancha, 02006, Spain
-
Hospital General Universitario Dr. Balmis
Alicante, Alicante, 03010, Spain
-
Hospital General Universitario de Elche
Elche, Alicante, 03203, Spain
-
Hospital Universitari Son Espases
Palma de Mallorca, Balearic Islands, 07120, Spain
-
Hospital Universitario Burgos
Burgos, Castille and León, 09006, Spain
-
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, 33011, Spain
-
Hospital Universitario Mare de Déu de la Mercé
Barcelona, Barcelona, 08035, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Madrid, 28034, Spain
-
Hospital Universitario y Politécnico La Fe
Valencia, València, 46026, Spain
Conditions
Explore the condition pages connected to this study.